No Clear Winner in Trial of Tests for Low-Risk Prostate Cancer
Two commonly used assays for the severity of prostate cancer performed equally well in a head-to-head trial.
New York United States Memorial Sloan Kettering Cancer Center University Of Houston Stephen Spann Brian Helfand
Source: medscape.com